Please ensure Javascript is enabled for purposes of website accessibility

DexCom and Livongo Health Team up in Glucose Data Deal

By Eric Volkman - Updated Jan 16, 2020 at 12:12PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Data from DexCom's continuous glucose monitoring system will be available to users of Livongo's software platform.

Two companies active in the diabetes segment, DexCom (DXCM 3.01%) and Livongo Health (LVGO) announced on Monday they were collaborating on user data dissemination. In a joint press release, the two companies said that users of Livongo's health information platform would be able to sync their data from DexCom's G6 glucose (blood sugar) monitoring system.

The two companies said this will allow Livongo users to utilize that data with other information tracked by the platform, such as weight and blood pressure, to obtain a deeper understanding of the state of their health.

DexCom Continuous Glucose Monitor

Image Source: DexCom

"Livongo can now aggregate data from the Dexcom G6, cross-reference with proprietary blood pressure and weight data from its connected devices, and then use advanced data science to interpret that data and offer Members personalized health insights, or Health Nudges, based on their comprehensive health profile," the companies wrote in their announcement.

At the end of September, the Livongo software platform had over 770 customers. The system allows users to monitor and manage chronic illnesses, particularly type 2 diabetes. It can also track developments in hypertension, among other health issues.

DexCom is a specialist in continuous glucose monitoring (CGM); its G6 is a product that takes readings from a small sensor inserted just under the skin. The readings are transmitted wirelessly and can be monitored on a display device such as a smartphone.

DexCom and Livongo did not provide the terms or the financial details of their new arrangement.

On Monday, the paths of the two healthcare stocks diverged. Livongo's shares closed up by nearly 6%. In contrast, DexCom's were down, albeit only marginally. 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

DexCom, Inc. Stock Quote
DexCom, Inc.
$289.08 (3.01%) $8.45
Livongo Health, Inc. Stock Quote
Livongo Health, Inc.

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.